共 20 条
[1]
Nakamae H(2010)Low-dose total body irradiation and fludarabine conditioning for HLA-Class I mismatched donor stem cell transplantation and immunological recovery in patients with hematological malignancies: a multi-center trial Biol. Blood. Marrow. Transplant. 16 1972-1980
[2]
Ballen KK(2012)Selection of optimal alternative graft source: mismatched unrelated donor, umbilical cord blood, or haploidentical transplant Blood. 119 4576-4583
[3]
Koreth J(2007)High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation Blood. 110 1333-1338
[4]
Chen YB(2015)Composite end point of graft-versus-host disease-free, relapse-free survival after allogeneic hematopoietic cell transplantation Blood. 125 295-304
[5]
Dey BR(1974)Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors Transplantation. 18 204-217
[6]
Spitzer TR(1980)Chronic graft-versus-host syndrome in man: a long-term clinicopathologic study of 20 Seattle patients Am. J. Med. 69 2596-2606
[7]
Lee SJ(2014)Nonpermissive HLA-DPB1 mismatch increases mortality after myeloablative unrelated allogeneic hematopoietic cell transplantation Blood. 124 885-892
[8]
Holtan SG(2011)HLA-C antigen mismatch is associated with worse outcome in unrelated donor peripheral blood stem cell transplantation Biol. Blood. Marrow. Transplant. 17 1923-1930
[9]
Glucksberg H(2004)Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome Blood. 104 4075-4083
[10]
Shulman HM(2000)Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group study Blood. 96 3189-3197